Pumpkin Seed Oil as a Nutraceutical for Hemodialysis Patients
In plain words A study of pumpkin seed oil in people 18 and older, run by Al-Mustansiriyah University. It plans to enroll about 100 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 and older. Conditions: End Stage Renal Disease; Chronic Kidney Disease Requiring Chronic Dialysis; Inflammation; Oxidative Stress.
- End-stage renal disease (ESRD) on hemodialysis for more than 6 months, on a constant dialysis program.
- Hemodynamically stable (no recent hospitalization for infections, cardiovascular events, or major surgery within the past 3 months).
- No active acute infections.
- Serum albumin ≥ 3.0 g/dL.
The exclusion criteria are on the listing.
What it tests, as registered
Pumpkin Seed Oil 1000 mg; Standard hemodialysis care
Registered summary
Patients with end-stage renal disease (ESRD) on maintenance hemodialysis experience chronic systemic inflammation, oxidative stress, and dyslipidemia, which together drive much of the excess cardiovascular morbidity and mortality seen in this population. Pumpkin seed oil is a nutraceutical rich in polyunsaturated fatty acids, phytosterols,and tocopherols, with documented antioxidant, anti-inflammatory, and antihyperlipidemic properties in preclinical and limited clinical studies. The full summary is on the listing.
Where, as registered
No US site; Iraq (1).